Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3244-3247, August 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lange, P. H.
Right arrow Articles by Fishman, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lange, P. H.
Right arrow Articles by Fishman, W. H.

Placental Alkaline Phosphatase as a Tumor Marker for Seminoma1

Paul H. Lange2, Jose L. Millan, Torgny Stigbrand, Robert L. Vessella, Erkki Ruoslahti and William H. Fishman

Departments of Urologic Surgery, University of Minnesota College of Health Sciences, and Veterans Administration Medical Center, Minneapolis, Minnesota 55455 [P. H. L., R. L. V.]; La Jolla Cancer Research Foundation, La Jolla, California 92037 [J. L. M., E. R., W. H. F.]; and Department of Physiological Chemistry, University of Umea, Umea, Sweden [T. S.]

A sensitive and specific enzyme-linked immunoabsorbent assay was used in a retrospective study of serum levels of placental alkaline phosphatase (PLAP) in testicular cancer. Sixteen of 28 men with active seminoma had elevated PLAP levels, and 71% had elevated levels of either PLAP, human chorionic gonadotropin, or both. Only four of 22 men with active nonseminomatous cancer had elevated PLAP levels, and the levels were normal in all control patients, including 33 men apparently cured of testicular cancer. In six of ten serial studies, PLAP levels provided information not otherwise available that would have been useful clinically, and the levels never were elevated inappropriately. Our data suggest that PLAP is a clinically useful serum tumor marker for seminoma.

1 Supported by Grants CA 21967 and Cancer Center Support Grant CA 30199 from the National Cancer Institute and by research funds from the Veterans Administration.

2 To whom requests for reprints should be addressed, at Department of Urologic Surgery, University of Minnesota Health Sciences, Box 394, Mayo Memorial Building, Minneapolis, Minn. 55455.

Received 10/ 6/81. Accepted 4/28/82.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem., December 1, 2008; 54(12): e11 - e79.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S Narisawa, M. Hofmann, C. Ziomek, and J. Millan
Embryonic alkaline phosphatase is expressed at M-phase in the spermatogenic lineage of the mouse
Development, January 9, 1992; 116(1): 159 - 165.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.